XERS insider transaction filings
Xeris Biopharma Holdings, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-21. Screen XERS transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-21 | 4 | Shannon John Patrick Jr — See Remarks, Director | Tax withholding (F): 36,645 @ $8.08 | EDGAR |
| 2026-08-21 | 4 | McCulloch Kevin — See Remarks | Tax withholding (F): 21,918 @ $8.08 | EDGAR |
| 2026-08-12 | 4 | Pieper Steven — See Remarks | Sale (S): 5,000 @ $8.50 | EDGAR |
| 2026-08-04 | 4 | McCulloch Kevin — See Remarks | Sale (S): 15,000 @ $8.02 | EDGAR |
| 2026-08-04 | 4 | Hecht Beth — See Remarks | Sale (S): 16,666 @ $8.01 | EDGAR |
| 2026-07-07 | 4 | Pieper Steven — See Remarks | Sale (S): 17,400 @ $8.50 · Sale (S): 27,600 @ $8.52 | EDGAR |
| 2026-07-02 | 4 | McCulloch Kevin — See Remarks | Sale (S): 90,000 @ $8.03 | EDGAR |
| 2026-07-02 | 4 | KREHER NERISSA — Director | Grant/award (A): 33,582 @ $0 · Grant/award (A): 37,910 (derivative) @ $8 | EDGAR |
| 2026-07-02 | 4 | Hecht Beth — See Remarks | Sale (S): 16,666 @ $8.03 | EDGAR |
| 2026-06-05 | 4 | Brady James Aloysius — Director | Grant/award (A): 24,193 @ $0 · Grant/award (A): 32,996 (derivative) @ $6.15 | EDGAR |
| 2026-06-05 | 4 | HALKUFF DAWN — Director | Sale (S): 20,000 @ $6.09 · Grant/award (A): 24,193 @ $0 · Grant/award (A): 32,996 (derivative) @ $6.15 | EDGAR |
| 2026-06-05 | 4 | BORMANN-KENNEDY BARBARA-JEAN ANNE — Director | Sale (S): 16,000 @ $6.09 · Grant/award (A): 24,193 @ $0 · Grant/award (A): 32,996 (derivative) @ $6.15 | EDGAR |
| 2026-06-05 | 4 | Kong Garheng — Director | Grant/award (A): 24,193 @ $0 · Grant/award (A): 32,996 (derivative) @ $6.15 | EDGAR |
| 2026-06-05 | 4 | JOHNSON JOHN — Director | Sale (S): 15,000 @ $6.09 · Grant/award (A): 24,193 @ $0 · Grant/award (A): 32,996 (derivative) @ $6.15 | EDGAR |
| 2026-06-05 | 4 | PERSKY MARLA — Director | Sale (S): 15,500 @ $5.90 · Grant/award (A): 24,193 @ $0 · Grant/award (A): 32,996 (derivative) @ $6.15 | EDGAR |
| 2026-06-02 | 4 | Hecht Beth — See Remarks | Sale (S): 16,667 @ $6.06 | EDGAR |
| 2026-05-01 | 4 | Hecht Beth — See Remarks | Sale (S): 16,667 @ $6.23 | EDGAR |
| 2026-04-03 | 4 | Hecht Beth — See Remarks | Sale (S): 16,667 @ $5.99 | EDGAR |
| 2026-04-01 | 4 | Brady James Aloysius — Director | Sale (S): 10,834 @ $5.54 | EDGAR |
| 2026-03-16 | 4 | McCulloch Kevin — See Remarks | Option exercise (M): 48,894 @ $4.09 · Option exercise (M): 4 @ $3.94 · Option exercise (M): 48,894 (derivative) @ $4.09 · Option exercise (M): 4 (derivative) @ $3.94 | EDGAR |
| 2026-03-05 | 4 | Pieper Steven — See Remarks | Option exercise (M): 27,891 @ $4.09 · Option exercise (M): 14,036 @ $5.93 · Option exercise (M): 27,891 (derivative) @ $0 · Option exercise (M): 14,036 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Hecht Beth — See Remarks | Sale (S): 16,567 @ $6.24 · Sale (S): 100 @ $7.06 | EDGAR |
| 2026-02-25 | 4 | Nguyen Anh Tu — See Remarks | Tax withholding (F): 29,300 @ $6.88 | EDGAR |
| 2026-02-02 | 4 | Nguyen Anh Tu — See Remarks | Grant/award (A): 121,293 @ $0 · Grant/award (A): 162,162 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | McCulloch Kevin — See Remarks | Grant/award (A): 168,463 @ $0 · Tax withholding (F): 68,454 @ $7.36 · Tax withholding (F): 30,289 @ $7.36 · Tax withholding (F): 27,319 @ $7.36 · Grant/award (A): 225,225 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | Pieper Steven — See Remarks | Grant/award (A): 154,986 @ $0 · Tax withholding (F): 111,765 @ $7.36 · Tax withholding (F): 66,450 @ $7.36 · Tax withholding (F): 27,319 @ $7.36 · Grant/award (A): 207,207 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | Hecht Beth — See Remarks | Grant/award (A): 121,293 @ $0 · Tax withholding (F): 98,375 @ $7.36 · Tax withholding (F): 46,914 @ $7.36 · Tax withholding (F): 24,266 @ $7.36 · Sale (S): 16,667 @ $7.45 · Grant/award (A): 162,162 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | Shannon John Patrick Jr — See Remarks, Director | Grant/award (A): 478,436 @ $0 · Tax withholding (F): 118,134 @ $7.36 · Tax withholding (F): 111,621 @ $7.36 · Tax withholding (F): 110,750 @ $7.36 · Grant/award (A): 639,639 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | McCulloch Kevin — See Remarks | Sale (S): 15,000 @ $8 | EDGAR |
| 2026-01-06 | 4 | Shannon John Patrick Jr — See Remarks, Director | Sale (S): 24,907 @ $7.08 · Option exercise (M): 64,265 @ $1.55 · Option exercise (M): 25,136 @ $1.55 · Option exercise (M): 2,900 @ $3.94 · Option exercise (M): 64,265 (derivative) @ $0 · Option exercise (M): 25,136 (derivative) @ $0 · +1 more | EDGAR |
| 2026-01-05 | 4 | Hecht Beth — See Remarks | Sale (S): 16,667 @ $7.43 | EDGAR |
| 2025-12-19 | 4 | JOHNSON JOHN — Director | Sale (S): 135,400 @ $7.22 | EDGAR |
| 2025-12-15 | 4 | BORMANN-KENNEDY BARBARA-JEAN ANNE — Director | Sale (S): 15,000 @ $7.09 | EDGAR |
| 2025-12-02 | 4 | Hecht Beth — See Remarks | Sale (S): 16,667 @ $7.01 | EDGAR |
| 2025-11-17 | 4 | Shannon John Patrick Jr — See Remarks, Director | Option exercise (M): 8,970 @ $1.55 · Sale (S): 23,242 @ $7.46 · Option exercise (M): 87,100 @ $1.55 · Option exercise (M): 8,970 (derivative) @ $0 · Option exercise (M): 87,100 (derivative) @ $0 | EDGAR |
| 2025-11-13 | 4 | Hecht Beth — See Remarks | Sale (S): 16,667 @ $7.40 | EDGAR |
| 2025-10-03 | 4 | McCulloch Kevin — See Remarks | Tax withholding (F): 733 @ $8.31 | EDGAR |
| 2025-09-15 | 4 | McCulloch Kevin — See Remarks | Other (J): 2,000 @ $0 | EDGAR |
| 2025-09-12 | 4 | PERSKY MARLA — Director | Sale (S): 15,500 @ $7.72 | EDGAR |
| 2025-08-29 | 4 | SHERMAN JEFFREY W — Director | Option exercise (M): 47,040 @ $6.66 · Sale (S): 42,232 @ $7.92 · Option exercise (M): 47,040 (derivative) @ $0 | EDGAR |
| 2025-08-15 | 4 | JOHNSON JOHN — Director | Sale (S): 107,500 @ $7.32 | EDGAR |
| 2025-08-13 | 4 | HALKUFF DAWN — Director | Sale (S): 42,500 @ $7.28 | EDGAR |
| 2025-08-04 | 4 | McCulloch Kevin — See Remarks | Tax withholding (F): 14,651 @ $5.38 | EDGAR |
| 2025-08-04 | 4 | Shannon John Patrick Jr — See Remarks, Director | Tax withholding (F): 36,918 @ $5.38 | EDGAR |
| 2025-06-16 | 4 | McCulloch Kevin — See Remarks | Purchase (P): 25,000 @ $4.38 | EDGAR |
| 2025-06-04 | 4 | HALKUFF DAWN — Director | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2025-06-04 | 4 | BORMANN-KENNEDY BARBARA-JEAN ANNE — Director | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2025-06-04 | 4 | Kong Garheng — Director | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2025-06-04 | 4 | JOHNSON JOHN — Director | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2025-06-04 | 4 | PERSKY MARLA — Director | Grant/award (A): 50,000 @ $0 | EDGAR |
Recent 8-K events — Xeris Biopharma Holdings, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-17 | 8-K | 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events | EDGAR |
| 2026-06-30 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-05 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
| 2026-04-21 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-03-02 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-27 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-08 | 8-K | 2.02 — Results of Operations and Financial Condition | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=XERS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →